We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Nanopore Technologies Plc | LSE:ONT | London | Ordinary Share | GB00BP6S8Z30 | ORD GBP0.0001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.70 | 3.22% | 150.50 | 150.10 | 150.50 | 152.00 | 145.80 | 146.20 | 526,081 | 15:40:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 169.67M | -154.51M | -0.1641 | -9.17 | 1.37B |
Date | Subject | Author | Discuss |
---|---|---|---|
01/5/2024 13:21 | My feeling is that post Brexit, whether by correlation or causation, UK Plc is like the housing market in 1996. It's a buyer's market. And the tech crown jewels - with double discount of currency depreciation and LSE low value assumptions- are to had for peanuts. Such things do change, though I fear UK will be out in the cold for a generation, and will lose a large section of its most promising growth companies. | brucie5 | |
01/5/2024 11:42 | I've never really put much weight behind this being taken out, but changed my view recently. It certainly adds a bit of jeopardy to selling to take a little profit. One of the big boy LSTools could acquire this for a rounding error and it would add a disproportionate amount of 'value'. They have the customers, routes to market, geographic footprint, synergy etc etc. Pre or post breakeven? Who knows. They won't want a business that's just going to burn through cash and destroy their own EBITDA, but I'd be doing some serious DD if I were a CEO. It's a high value space waiting to be dominated. Given the difficulty of building a start up to here, despite having the benefit of a very well funded (at the time ) cornerstone investor backing all the way, I would still have good confidence in GS pushing a very good deal. | 32v31today | |
01/5/2024 09:53 | Maybe start with the premise that this will be bought out in due course; it's just too enormous not to. Add the expiry of LAT shares in June. Whack in the 3.5% subscription by Biomerieux at 2.38 last October. Sprinkle over with heavy director buys in the region of 1.30, or thereabouts; not to mention some recent light seasoning by a NED as reported this morning. Heat up with the strategic ambiguity of the 15m reported last night. It may go lower; it may not. | brucie5 | |
01/5/2024 09:27 | Should get a holding statement one way or other?looking to buy | tsmith2 | |
01/5/2024 07:31 | Small fry 23k, but every little helps. | brucie5 | |
01/5/2024 07:07 | More director buying... follow the money buy | seball | |
01/5/2024 05:49 | Given share price weakness would think it was a sellmay have cleared seller - let's see today | tsmith2 | |
30/4/2024 23:25 | Looking at prices over the past few trading days, this is likely a late reported trade from Friday and could therefore equally be seen a buy. | bamboo2 | |
30/4/2024 20:28 | Just seen it on LSE, thanks. That's huge. 15M sell at 97p. | brucie5 | |
30/4/2024 19:49 | Volume 15m. Could seller be finished? | bamboo2 | |
30/4/2024 16:46 | And there go. Sellers seem unwilling to let this go. | brucie5 | |
30/4/2024 11:13 | Added. Now watch it slip below £1 again. ;) | brucie5 | |
30/4/2024 10:55 | Trading update July | tsmith2 | |
30/4/2024 09:16 | Well way I see it, it's started to test likely new support at £. | brucie5 | |
30/4/2024 08:53 | buying in if we get reversal on strength here | tsmith2 | |
30/4/2024 06:39 | Sounds like more waiting on the next ONT results for confirmation of some sort of stabilisation/start of a demand recovery I suppose for me. The challenge is that the market seems to sometimes appreciate before the results (e.g. OXB) and buying in after a spike changes the risk/reward a bit - the joys of investing in recovery plays :) | takeiteasy | |
29/4/2024 21:39 | One take I had from the recent pacb update was how terrible the end market is / has been. I think it hit them more than others. LSTools seem to have reported a better than expected tough period and looking at things picking up further in H2. This isn't based on a particularly deep dive, but nervousness from pacb will hit ONT. Bottom line for me, hopefully end market is picking up from here. I think Bruce nailed calling these prices a while back. My take is that, long term, this is massively mispriced by the market, and so an opportunity (unless you're dipping in and out every 5 minutes, in which case, who knows) . I'd expect to see the price improve very materially during 2024 (so expect it to go down ;) )My view on current price decline is potentially influenced big holders selling down and end market has been really difficult recently. Both of which have hopefully turned/ turning, both of which are hopefully good for share price. That said I've not done any sums on that.Reasons to buy not sell in my book. | 32v31today | |
29/4/2024 18:52 | Yes. ;) | brucie5 | |
29/4/2024 18:24 | PACB on Nasdaq on a healthy rise up for once - is this stock specific or is there a reconsideration for this sector underway at all | takeiteasy | |
26/4/2024 16:59 | You could see 1.15 without any change in the chart direction. This is just profoundly oversold, afaic. Don't forget BioMerieux agreed to buy 3.5% at 2.38 last October; and very substantial, recent dir buys at £1 below that. I see a rare historic opportunity at these levels, but obviously there are risks, so each to their own. Of three analogous situations I follow: OXB starting to recover - ahead of results on Monday; CWR may also have based out. As to the 'double bottom' here - yes, very possible, though no telling there might not be a third. Depends if there is another large seller still to come. Absolutely NAI. | brucie5 | |
26/4/2024 16:12 | I'm wanting to see a mover up through £1.05 on good volume before dipping toe | tsmith2 | |
26/4/2024 16:08 | Double bottom. Technically things are pointing to 150p in short order. Buy | seball | |
26/4/2024 15:27 | double bottom? | tsmith2 | |
26/4/2024 11:54 | Yes I agree once they expire in June things could get very interesting..... BUY | seball | |
26/4/2024 11:34 | I see DARK has just been snaffled by a US company. Our pockets are being rifled. I very much suspect that ONT will go the same way once the LAT shares expire in June. | brucie5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions